Global multi-omics market, which largely includes genomics, transcriptomics, proteomics, and metabonomics, is expected to increase at a pace of 16%.
The next phase of expansion is expected to be driven by expanding demand for customized treatment, technological improvements, a favorable financing environment, an increasing number of cancer and genetic illnesses, and an increase in R&D expenditure. To learn more about the research report, download a sample report. Omics has emerged as a new paradigm in molecular research. The suffix -omics refers to a branch of research in biological sciences. Many areas of research can be classed as omics, including genomes, transcriptomics, proteomics, and metabolomics. Genomics studies genes and […]
Continue Reading